A novel mutation of PAX6 in Chinese patients with new clinical features of Peters' anomaly.

Xiuhua Jia, Xiangming Guo, Xiaoyun Jia, Xueshan Xiao, Shiqiang Li, Qingjiong ZhangPubMed 2010

TL;DR

Researchers have identified a novel mutation in the PAX6 gene, a key player in eye development, in a Chinese infant with severe Peters' anomaly. This discovery expands our understanding of the genetic basis of this rare condition and highlights how variations in PAX6 can lead to a wide spectrum of ocular malformations.

What Problem Does This Paper Address?

Peters' anomaly is a congenital eye disorder characterized by corneal opacity and other anterior segment abnormalities. While mutations in the PAX6 gene are known to cause various eye malformations, including aniridia and, less commonly, Peters' anomaly, the specific genetic underpinnings and the full spectrum of clinical presentations, especially in diverse populations like Chinese patients, are not fully understood. This study aims to identify novel PAX6 mutations in Chinese patients with Peters' anomaly and to characterize the associated clinical features, thereby enriching our knowledge of genotype-phenotype correlations.

Methods

The researchers employed a multi-pronged approach:

  • Clinical Evaluation: A detailed ophthalmological examination was performed on a 10-month-old male infant presenting with corneal opacity and nystagmus. This included slit-lamp microscopy, A/B ultrasonography, and electroretinography (ERG) to assess the severity and extent of ocular malformations.
  • Genetic Analysis: Genomic DNA was extracted from the patient's blood. The coding regions and adjacent intronic sequences of the PAX6 gene were amplified using polymerase chain reaction (PCR). These amplified fragments were then analyzed by direct sequencing to identify any variations.
  • Mutation Confirmation: To confirm the identified variation, it was further evaluated in 100 healthy control individuals using heteroduplex-single strand conformational polymorphism (SSCP) analysis. Bidirectional sequencing was also used to confirm the mutation.
  • Bioinformatic Analysis: The identified mutation was analyzed for its potential impact on the PAX6 protein structure and function using bioinformatic tools like PolyPhen. Conservation of the affected amino acid residue across different species was also assessed.

Datasets

  • Patient Data: A single Chinese infant diagnosed with Peters' anomaly.
  • Control Data: DNA samples from 100 healthy Chinese individuals were used for mutation screening.
  • Reference Genomes: NCBI human genome build 35.1 and human PAX6 gene sequences (NM_001604.3 for cDNA, NP_001595.2 for protein) were used for primer design and sequence alignment.

Key Insights and Ideas

  • Novel PAX6 Mutation Identified: The study successfully identified a previously unreported heterozygous mutation (c.51C>A) in the PAX6 gene in a Chinese patient with severe Peters' anomaly.
  • Impact on Protein Structure: This mutation results in a significant amino acid change (p.Asn17Lys) within the bipartite paired DNA-binding domain of the PAX6 protein. This change alters a highly conserved residue, suggesting a critical role in protein function.
  • Severe Ocular Phenotype: The identified mutation is associated with a severe presentation of Peters' anomaly, including microcornea, microphthalmia, corneal leukoma with anterior synechia, anterior polar cataracts, and inability to dilate pupils due to posterior synechia.
  • Broader Mutation Spectrum: This finding contributes to the expanding spectrum of PAX6 mutations associated with ocular malformations, particularly in the context of Peters' anomaly.
  • Genotype-Phenotype Correlation: The study reinforces the idea that PAX6 mutations can lead to a wide range of ocular defects, and this specific missense mutation in the DNA-binding domain can cause severe anterior segment abnormalities.

Key Results

  • A novel heterozygous mutation, c.51C>A in PAX6, was identified in the patient.
  • This mutation leads to a p.Asn17Lys amino acid substitution at codon 17, located within the bipartite paired DNA-binding domain of PAX6.
  • The mutation was absent in 100 control individuals, confirming its novelty and association with the patient's condition.
  • The patient exhibited severe ocular malformations consistent with Peters' anomaly, including corneal opacity, nystagmus, microcornea, microphthalmia, anterior polar cataracts, and iris abnormalities.
  • ERG examination revealed retinal dysphasia with reduced rod and cone responses, and B-scanning showed abnormalities in the vitreous body and optic nerve.

Limitations and Future Work

  • Single Patient Study: The study is based on a single patient, which limits the generalizability of the findings. While the mutation was confirmed, further studies with larger cohorts are needed to fully understand the prevalence and variability associated with this specific mutation.
  • Contribution of Other Genes: The authors suggest that additional genes with unknown functions in anterior segment development might contribute to the spectrum of Peters' anomaly, especially given the relatively low prevalence of PAX6 mutations in sporadic cases.
  • Further Functional Studies: While bioinformatic analysis predicted a "probable damaging" effect, further in vitro and in vivo functional studies are warranted to elucidate the precise molecular mechanisms by which the p.Asn17Lys mutation affects PAX6 protein function and leads to the observed developmental defects.
  • Correlating Phenotype to Mutation Site: The authors emphasize the need for further studies to correlate the specific site of missense mutations within PAX6 with the observed phenotype, which will help in better understanding genotype-phenotype relationships.

Summary updated

Abstract

PAX6 mutations cause ocular malformations that vary considerably in pattern and severity. In this study, we identified one novel mutation in PAX6 in a patient with severe ocular clinical features of Peters' anomaly. This finding expands the mutation spectrum in PAX6 and enriches our knowledge of genotype-phenotype relations due to PAX6 mutations.
BibTeX
@inproceedings{jia2010novel,
  author = {Xiuhua Jia and Xiangming Guo and Xiaoyun Jia and Xueshan Xiao and Shiqiang Li and Qingjiong Zhang},
  title = {{A novel mutation of PAX6 in Chinese patients with new clinical features of Peters' anomaly.}},
  booktitle = {PubMed},
  year = {2010},
}
Figure